Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $9.6400 (10.87%) ($9.6400 - $9.6400) on Wed. Feb. 22, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.73% (three month average) | RSI | 41 | Latest Price | $9.6400(10.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.4% a day on average for past five trading days. | Weekly Trend | BCRX declines -4.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(37%) XBI(29%) IBB(26%) SDY(26%) XLRE(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.865% in a week (0% probabilities). VIXM(-15%) UUP(-9%) VXX(-7%) EDOC(-3%) SMH(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.865% (StdDev 3.73%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.26(-86.93%) | Resistance Level | $10.27 | 5 Day Moving Average | $9.71(-0.72%) | 10 Day Moving Average | $9.98(-3.41%) | 20 Day Moving Average | $10.27(-6.13%) | To recent high | -28.1% | To recent low | 10.9% | Market Cap | $1.701b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |